PANTOPRAZOLE SODIUM
NDC 64980-676, PANTOPRAZOLE SODIUM, tablet, delayed release, from Rising Pharma Holdings, Inc..
- Product NDC
- 64980-676
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA219087
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/64980-676 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PANTOPRAZOLE SODIUM20 mg/1
Pharmacologic classes
Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 64980-676-09 | 64980067609 | 90 TABLET, DELAYED RELEASE in 1 BOTTLE (64980-676-09) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/91a6b13f-457f-4136-9541-c4adb9c3c35cNADAC price for package 64980067609
GET /v1/drugs/nadac/64980067609
Use it
Look up 64980-676 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/64980-676 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 64980-676. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.